PT1117409E - Benzenossulfonil (tio) ureias em associacao com betabloqueantes para o tratamento de disfuncoes do sistema nervoso autonomo - Google Patents

Benzenossulfonil (tio) ureias em associacao com betabloqueantes para o tratamento de disfuncoes do sistema nervoso autonomo

Info

Publication number
PT1117409E
PT1117409E PT99944585T PT99944585T PT1117409E PT 1117409 E PT1117409 E PT 1117409E PT 99944585 T PT99944585 T PT 99944585T PT 99944585 T PT99944585 T PT 99944585T PT 1117409 E PT1117409 E PT 1117409E
Authority
PT
Portugal
Prior art keywords
ureias
betablets
benzenosulfonil
autonomous
tio
Prior art date
Application number
PT99944585T
Other languages
English (en)
Inventor
Holger Heitsch
Klaus Wirth
Heinrich Christian Englert
Heinz Gogelein
Bohn Helmut
Gerlach Uwe
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1998141534 external-priority patent/DE19841534A1/de
Priority claimed from DE1999101061 external-priority patent/DE19901061A1/de
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PT1117409E publication Critical patent/PT1117409E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42Sulfonylthioureas; Sulfonylisothioureas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52Y being a hetero atom
    • C07C311/54Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/58Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/54Silicon-containing compounds
    • C08K5/5406Silicon-containing compounds containing elements other than oxygen or nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT99944585T 1998-09-10 1999-09-02 Benzenossulfonil (tio) ureias em associacao com betabloqueantes para o tratamento de disfuncoes do sistema nervoso autonomo PT1117409E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1998141534 DE19841534A1 (de) 1998-09-10 1998-09-10 Verwendung von Benzolsulfonyl(thio)harnstoffen zur Behandlung und Prophylaxe von Dysfunktionen des autonomen Nervensystems und Verwendung von Benzolsulfonyl(thio)harnstoffen in Kombination mit Betarezeptoren-Blockern
DE1999101061 DE19901061A1 (de) 1999-01-14 1999-01-14 Verwendung von Benzolsulfonyl(thio)harnstoffen zur Behandlung von Prophylaxe von Dysfunktionen des autonomen Nervensystems und Verwendung von Benzolsulfonyl(thio)harnstoffen in Kombination mit Betarezeptoren-Blockern

Publications (1)

Publication Number Publication Date
PT1117409E true PT1117409E (pt) 2005-04-29

Family

ID=26048790

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99944585T PT1117409E (pt) 1998-09-10 1999-09-02 Benzenossulfonil (tio) ureias em associacao com betabloqueantes para o tratamento de disfuncoes do sistema nervoso autonomo

Country Status (27)

Country Link
US (1) US6414030B1 (pt)
EP (1) EP1117409B1 (pt)
JP (1) JP4733268B2 (pt)
KR (1) KR100981592B1 (pt)
CN (1) CN1195524C (pt)
AR (1) AR020411A1 (pt)
AT (1) ATE287718T1 (pt)
AU (1) AU762832B2 (pt)
BR (1) BR9913572A (pt)
CA (1) CA2343009C (pt)
CZ (1) CZ301165B6 (pt)
DE (1) DE69923464T2 (pt)
DK (1) DK1117409T3 (pt)
ES (1) ES2235507T3 (pt)
HK (1) HK1040187B (pt)
HU (1) HU228988B1 (pt)
ID (1) ID28854A (pt)
IL (2) IL141414A0 (pt)
MY (1) MY121798A (pt)
NO (1) NO330215B1 (pt)
NZ (1) NZ510424A (pt)
PL (1) PL194986B1 (pt)
PT (1) PT1117409E (pt)
RU (1) RU2247562C2 (pt)
TR (1) TR200100692T2 (pt)
TW (1) TWI238817B (pt)
WO (1) WO2000015204A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19917233A1 (de) * 1999-04-16 2000-10-19 Aventis Pharma Gmbh Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids
DE19923086A1 (de) 1999-05-20 2000-11-23 Aventis Pharma Gmbh Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US7620611B1 (en) * 1999-07-20 2009-11-17 Trilithic, Inc. Neural networks for ingress monitoring
DE10054482A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10054481A1 (de) * 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10129704A1 (de) * 2001-06-22 2003-01-02 Aventis Pharma Gmbh Verwendung von Benzolsulfonyl(thio)harnstoffen in der Behandlung des septischen Schocks
CN1330630C (zh) * 2004-03-10 2007-08-08 中国药科大学 新的磺酰(硫)脲衍生物、其制备方法及含有它们的药物组合物
DE102004061017A1 (de) * 2004-12-18 2006-06-22 Sanofi-Aventis Deutschland Gmbh Piperidinsulfonylharnstoffe und -thioharnstoffe, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
MX2009012644A (es) * 2007-06-05 2009-12-10 Sanofi Aventis Derivados de di(hetero)arilciclohexano, su preparacion, su uso y composiciones farmaceuticas que los comprenden.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1185180B (de) * 1963-10-19 1965-01-14 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE1518874C3 (de) * 1964-10-07 1975-03-13 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DE3009047A1 (de) 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Neue l-(acylamino-aryloxy-)2-hydroxy-3-alkinylaminopropane und verfahren zu ihrer herstellung
GB8716972D0 (en) * 1987-07-17 1987-08-26 Pfizer Ltd Treatment of cardiac arrhythmias
DK0612724T3 (da) * 1993-02-23 1997-06-16 Hoechst Ag Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling og deres anvendelse som farmaceutika
DE19505397A1 (de) 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
MX9706744A (es) 1995-03-10 1997-11-29 Hoechst Marion Roussel Inc Proceso novedosos para preparar derivados de 2,3-dihidro-benzofuranol.
FR2746013B1 (fr) 1996-03-18 1998-05-29 Sanofi Sa Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus

Also Published As

Publication number Publication date
ATE287718T1 (de) 2005-02-15
WO2000015204A3 (en) 2000-07-13
PL347215A1 (en) 2002-03-25
EP1117409B1 (en) 2005-01-26
ES2235507T3 (es) 2005-07-01
MY121798A (en) 2006-02-28
NO20011117L (no) 2001-05-02
DK1117409T3 (da) 2005-05-30
CZ301165B6 (cs) 2009-11-25
HUP0103534A2 (hu) 2002-05-29
WO2000015204A2 (en) 2000-03-23
CZ2001858A3 (en) 2001-06-13
CA2343009C (en) 2011-03-15
NO330215B1 (no) 2011-03-07
NZ510424A (en) 2003-06-30
TWI238817B (en) 2005-09-01
US6414030B1 (en) 2002-07-02
AU762832B2 (en) 2003-07-03
HU228988B1 (hu) 2013-07-29
ID28854A (id) 2001-07-05
BR9913572A (pt) 2001-05-22
DE69923464T2 (de) 2006-05-11
CN1195524C (zh) 2005-04-06
CN1319014A (zh) 2001-10-24
CA2343009A1 (en) 2000-03-23
IL141414A (en) 2006-07-05
PL194986B1 (pl) 2007-07-31
AU5744499A (en) 2000-04-03
EP1117409A2 (en) 2001-07-25
HUP0103534A3 (en) 2003-09-29
TR200100692T2 (tr) 2001-07-23
JP2002524497A (ja) 2002-08-06
IL141414A0 (en) 2002-03-10
AR020411A1 (es) 2002-05-08
JP4733268B2 (ja) 2011-07-27
HK1040187B (zh) 2005-09-02
US20020082300A1 (en) 2002-06-27
KR20010086396A (ko) 2001-09-10
NO20011117D0 (no) 2001-03-05
DE69923464D1 (de) 2005-03-03
HK1040187A1 (en) 2002-05-31
KR100981592B1 (ko) 2010-09-13
RU2247562C2 (ru) 2005-03-10

Similar Documents

Publication Publication Date Title
BR9712948B1 (pt) unidade de terapia por fàtons e cabeÇote para tratamento de terapia de fàtons.
ITRM940150A0 (it) Procedimento per il trattamento di acque di scarico fortemente colorate.
PT1077940E (pt) 4-fenilpiperidinas novas para o tratamento de dermatoses pruriginosas
NO20003525L (no) Biologisk væskebehandlingssystem
BR9508886A (pt) Compostos e métodos para o tratamento de câncer
BR9911781B1 (pt) iluminador para terapia fotodinámica.
BR9401242A (pt) Sistema de tratamento de água
PT1083889E (pt) Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas
PT1023067E (pt) Utilizacao de inibidores do sistema renina-angiotensina para o tratamento da hipoxia ou da funcao metabolica deficiente
BR0014927B1 (pt) sistema e método para o tratamento de água.
PT1206436E (pt) Retinoides para o tratamento de enfisema
BR9707922A (pt) Cafeína e clemastina para tratamento de distúrbios respiratórios
PT1117409E (pt) Benzenossulfonil (tio) ureias em associacao com betabloqueantes para o tratamento de disfuncoes do sistema nervoso autonomo
ZA978639B (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections.
PT983275E (pt) Novos derivados do triptolido vantajosos para o tratamento de doencas autoimunes
DE60037258D1 (de) System zur verwaltung des endpunktschlages
NO306060B1 (no) Substituerte kanelsyreguanidider, deres anvendelse samt medikamenter inneholdende guanididene
GB2355196B (en) Companion animal therapeutic treat
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
IT1284087B1 (it) Sistema per monitorare trattamenti biocidi
PT1135134E (pt) Utilizacao de estimuladores do factor neurotrofico para o tratamento de doencas oftalmicas neurodegenerativas
DE19983519T1 (de) Vorrichtung zur Wärmebehandlung von Körpergewebe
PT970080E (pt) Derivados de imino-aza-antraciclinona para o tartamento de amiloidoses
BR0005806B1 (pt) processo e disposição para o comando da unidade de propulsão.
NO20012616L (no) Middel til behandling av erektil malfunksjon